Researchers at Moffitt Cancer Center in Florida have identified a new strategy to enhance the therapeutic efficacy of immune checkpoint...

In a new study, researchers have identified benefits of SARS-COV-2 mRNA vaccines for cancer patients undergoing immunotherapy. The...

Deciphering and modifying the composition of various gut bacteria may improve immune checkpoint blockade (ICB) treatment responses in...

Changes in the order, structure, and number of copies of tumour DNA could be the reason some skin cancers ultimately resist treatment,...

Findings from a recent phase II clinical trial show promising results for the immune checkpoint inhibitor nivolumab in the treatment of...

New findings suggest the development of cutaneous immune-related adverse events (cirAEs) is associated with better treatment efficacy and...

Findings from a new study suggest that inhibiting both the LAG-3 and PD-1 immune checkpoints in patients with previously untreated...

An analysis of real-world data has evaluated the incidence, type and severity of skin-related side effects of immune checkpoint inhibitors.